ESMO® 2025 Highlights: Presenter Vignette – Scott Tagawa

Dr. Scott Tagawa

Scott Tagawa

M.D., MS, FACP, FASCO

Weill Cornell Medicine

LBA6

Phase 3 trial of [177Lu]Lu-PSMA-617 combined with ADT + ARPI in patients with PSMA-positive metastatic hormone-sensitive prostate cancer (PSMAddition)